Menu UF Health Home Menu
 
Dr. Shannon Boye
lab tour cropped
Prev Next

Retinal Gene Therapy Group

Established in 1994, AAV vectors from the RGTG were the first to:
(Click on the image to see a larger view)

Retinal Gene Therapy Timeline

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recent News

Dr. Shannon Boye’s work on AAV vector development featured in Ophthalmology Times

Jul 24th, 2014

Dr. Shannon Boye is featured in an article from Ophthalmology Times about advances in the AAV vector for retinal gene therapy. Read the article here.

John D. Ash receives a $300,000 grant from the Foundation Fighting Blindness (FFB)

Aug 21st, 2013

John D. Ash was awarded  three year grant titled:  “Using AAV-STAT3 and AAV-PIM-1 vectors to induce broad-spectrum protection of photoreceptors and PRE” from the Foundation Fighting Blindness. This project has the […]

William Hauswirth receives the Llura Ligget Gund Award at this year’s FFB Visions Conference

Jul 2nd, 2013

The Foundation Fighting Blindness, a national non-profit organization dedicated to finding treatments and cures for blinding retinal diseases, recognizes William W. Hauswirth, Ph.D., of the University of Florida College of […]

Vision Researchers recognized at Office of Technology and Licensing’s Celebration of Innovation

Mar 14th, 2013

Faculty members from within the Department of Ophthalmology and the Center for Vision Research were recognized for having developed technologies that were licensed within the 2012 calendar year. Those recognized […]

Dr. Shannon Boye receives 2nd place prize in the 2013 ARVO Foundation/Merck Innovative Ophthalmology Research Award in Gene Therapy and Eye Disease

Mar 12th, 2013

Selection was based upon her paper, “The Human Rhodopsin Kinase Promoter in an AAV5 Vector Confers Rod- and Cone-Specific Expression in the Primate Retina” by a panel of esteemed ARVO […]